Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colleoni

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 28, 2025
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomesN Peradze, A Polizzi, E Pagan, et al.
ESMO Open|December 11, 2025
Breast surgery and systemic treatment continuation for patients with de novo metastatic breast cancer and locoregional oligoprogression: a cohort studyC Valenza, N Bianco, M Milano, et al.
Breast Cancer Research and Treatment|September 27, 2005
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgeryG Curigliano, J Y Petit, F Bertolini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Very young women (<35 years) with operable breast cancer: features of disease at presentationM Colleoni, N Rotmensz, C Robertson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni, N Rotmensz, G Peruzzotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019H J Burstein, G Curigliano, S Loibl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Prediction of response to primary chemotherapy for operable breast cancerM Colleoni, E Orvieto, F Nolé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheterM Mandalà, G Curigliano, P Bucciarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyM Colleoni, G Viale, D Zahrieh, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 28, 2025
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomesN Peradze, A Polizzi, E Pagan, et al.
ESMO Open|December 11, 2025
Breast surgery and systemic treatment continuation for patients with de novo metastatic breast cancer and locoregional oligoprogression: a cohort studyC Valenza, N Bianco, M Milano, et al.
Breast Cancer Research and Treatment|September 27, 2005
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgeryG Curigliano, J Y Petit, F Bertolini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Very young women (<35 years) with operable breast cancer: features of disease at presentationM Colleoni, N Rotmensz, C Robertson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni, N Rotmensz, G Peruzzotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019H J Burstein, G Curigliano, S Loibl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Prediction of response to primary chemotherapy for operable breast cancerM Colleoni, E Orvieto, F Nolé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheterM Mandalà, G Curigliano, P Bucciarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyM Colleoni, G Viale, D Zahrieh, et al.
Pageof 18